Yunnan Botanee Bio-Technology Group Co.LTD (SHE:300957)
China flag China · Delayed Price · Currency is CNY
41.92
+1.04 (2.54%)
May 6, 2026, 3:04 PM CST

SHE:300957 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
5,5015,3325,7075,7074,9984,008
Other Revenue
26.4826.4829.1120.5516.1214.63
5,5285,3595,7365,7275,0144,022
Revenue Growth (YoY)
-1.07%-6.58%0.15%14.23%24.65%52.57%
Cost of Revenue
1,4881,4041,5651,4621,262977.08
Gross Profit
4,0403,9554,1704,2663,7523,045
Selling, General & Admin
3,2203,1713,3793,0232,3911,926
Research & Development
214.28237.38295.17298.82254.7113.22
Other Operating Expenses
81.1273.4663.0647.4554.7152.12
Operating Expenses
3,5093,4793,7503,3822,7002,097
Operating Income
530.86475.48420.76883.61,052948.45
Interest Expense
-19.34-18.29-17.59-4.97-4.75-4.19
Interest & Investment Income
96.7797.9482.592.91100.8833.62
Currency Exchange Gain (Loss)
-2.1-2.1-1.23-0.720.03-0
Other Non Operating Income (Expenses)
4.31-1.55-17.25-215.84-1.72-0.53
EBT Excluding Unusual Items
610.49551.47467.2754.971,147977.35
Impairment of Goodwill
-30.55-30.55-90.69---
Gain (Loss) on Sale of Investments
31.6942.57177.55-17.24-5.5210.8
Gain (Loss) on Sale of Assets
2.272.65-4.150.69-0.030.52
Asset Writedown
-17.13-4-25---
Other Unusual Items
83.4154.3983.49130.3972.7529.21
Pretax Income
680.18616.54608.4868.821,2141,018
Income Tax Expense
132.5199.72113.61109.61163.33153.81
Earnings From Continuing Operations
547.67516.83494.79759.211,051864.06
Minority Interest in Earnings
-4.32-11.118.26-2.420.8-1.14
Net Income
543.34505.72503.05756.81,051862.92
Net Income to Common
543.34505.72503.05756.81,051862.92
Net Income Growth
53.25%0.53%-33.53%-28.02%21.83%58.77%
Shares Outstanding (Basic)
423421419423424407
Shares Outstanding (Diluted)
423421419423424407
Shares Change (YoY)
1.96%0.53%-0.85%-0.27%4.15%13.09%
EPS (Basic)
1.281.201.201.792.482.12
EPS (Diluted)
1.281.201.201.792.482.12
EPS Growth
50.31%--32.96%-27.82%16.98%40.40%
Free Cash Flow
956.62493.61316.48336.16416.02882.04
Free Cash Flow Per Share
2.261.170.760.800.982.17
Dividend Per Share
0.6500.6500.6000.6000.8000.600
Dividend Growth
8.33%8.33%-0.08%-24.94%33.33%33.33%
Gross Margin
73.08%73.80%72.71%74.48%74.83%75.71%
Operating Margin
9.60%8.87%7.34%15.43%20.99%23.58%
Profit Margin
9.83%9.44%8.77%13.21%20.97%21.45%
Free Cash Flow Margin
17.30%9.21%5.52%5.87%8.30%21.93%
EBITDA
638.93585.1536.65954.321,110968.11
EBITDA Margin
11.56%10.92%9.36%16.66%22.15%24.07%
D&A For EBITDA
108.06109.63115.8970.7258.2319.66
EBIT
530.86475.48420.76883.61,052948.45
EBIT Margin
9.60%8.87%7.34%15.43%20.99%23.58%
Effective Tax Rate
19.48%16.17%18.67%12.62%13.46%15.11%
Revenue as Reported
5,5285,3595,7365,5225,0144,022
Advertising Expenses
----1,5341,249
Source: S&P Global Market Intelligence. Standard template. Financial Sources.